Skip to content

Health— page 8

health

Sanofi avoids fine as EU accepts offer to stop disparaging rival vaccine

By Foo Yun Chee BRUSSELS, Oct 14 (Reuters) – French pharmaceutical company Sanofi has staved off a potential hefty fine after European Union antitrust regulators on Wednesday said they had accepted its offer to stop disparaging a rival flu vaccine. The European Commission opened an investigation in

· SRN Health
Sanofi avoids fine as EU accepts offer to stop disparaging rival vaccine
health

Factbox-What is lung adenocarcinoma, the cancer diagnosed in Pope Leo?

VATICAN CITY, Oct 14 (Reuters) – Pope Leo was diagnosed with lung adenocarcinoma after doctors removed the lower lobe of his right lung during surgery on Tuesday, the Vatican said. Here are some facts about the disease. WHAT IS IT? Adenocarcinoma is a type of cancer that forms in glandular cells, wh

· SRN Health
Factbox-What is lung adenocarcinoma, the cancer diagnosed in Pope Leo?
health

Lonza sets new mid-term targets, confirms 2026 outlook

Oct 14 (Reuters) – Swiss contract drug manufacturer Lonza set new mid-term targets and confirmed its 2026 outlook on Wednesday ahead of its capital markets day, while saying third-quarter performance was in line with expectations across its business areas. Lonza is seeking to become a pure-play drug

· SRN Health
Lonza sets new mid-term targets, confirms 2026 outlook
health

Australian court dismisses Cosette appeal to drop Mayne Pharma takeover

Oct 14 (Reuters) – Australia’s New South Wales Court of Appeal on Wednesday rejected Cosette Pharmaceuticals’ bid to terminate its takeover of Mayne Pharma, upholding a lower court ruling that the US-based drugmaker had no valid grounds to abandon the deal. Here are some of the details: • Cosette bi

· SRN Health
health

Zealand Pharma, Generate strike AI obesity drug deal worth up to $1.2 billion

Oct 13 (Reuters) – Danish obesity-drug developer Zealand Pharma has partnered with US biotechnology company Generate Biomedicines to develop protein-based treatments for obesity and other metabolic diseases using AI, in a deal worth up to $1.2 billion. Generate will receive $30 million upfront and u

· SRN Health
Zealand Pharma, Generate strike AI obesity drug deal worth up to $1.2 billion
health

Guinea-Bissau says it has not approved hepatitis B vaccine trial in newborns

BISSAU, Oct 13 (Reuters) – Guinea-Bissau’s transitional government said Tuesday it has not approved a proposed clinical trial of a hepatitis B vaccine in newborns, denying reports that the study had been authorized. The denial followed news reports that the Trump administration-funded study to asses

· SRN Health
health

CVS settles US Justice Department case over opioid prescriptions for $315 million

By Nate Raymond Oct 13 (Reuters) – CVS Health has agreed to pay $315 million to resolve allegations that the pharmacy chain operator unlawfully filled medically unnecessary prescriptions for addictive opioid painkillers, the US Justice Department said on Tuesday. The settlement resolves a case the d

· SRN Health
health

Nvidia buys stakes in French tech startups Doctolib, Genesis AI

PARIS, Oct 13 (Reuters) – US chipmaker Nvidia has agreed to buy stakes in French technology startups Doctolib and Genesis AI, the two French companies said on Tuesday. Doctolib said that Nvidia had agreed to buy a minority stake without specifying the size of the stake or its value, though it said t

· SRN Health
Nvidia buys stakes in French tech startups Doctolib, Genesis AI
health

Congo’s Ebola infections surpass 9,000, government report shows

Oct 13 (Reuters) – The number of confirmed Ebola cases in the Democratic Republic of Congo has risen above 9,000, government data showed on Tuesday, as responders struggle to slow transmission in multiple hotspots. The latest situation report from Congo’s public health institute put the number of ca

· SRN Health
Congo’s Ebola infections surpass 9,000, government report shows
health

BioNTech’s mRNA cancer therapy misses first goal in head and neck trial

Oct 13 (Reuters) – BioNTech said on Tuesday its experimental mRNA cancer immunotherapy failed to meet the first main goal of a mid-to-late-stage trial in patients with head and neck cancer. US-listed shares of the drug developer were down nearly 3% in early trading. • The trial tested the drug, BNT1

· SRN Health
BioNTech’s mRNA cancer therapy misses first goal in head and neck trial
health

Agilent to buy pathology software maker Proscia for $240 million

Oct 13 (Reuters) – Agilent Technologies said on Tuesday it would acquire pathology software maker Proscia for $240 million in cash, plus up to $30 million tied to future performance targets, as the laboratory equipment maker expands its push into AI-enabled diagnostics. Here are some more details: •

· SRN Health
health

Pope Leo leaves Vatican for hospital ahead of surgery on lung nodule

VATICAN CITY, Oct 13 (Reuters) – Pope Leo left the Vatican on Tuesday in a convoy of vehicles ahead of his expected admission to Rome’s Gemelli hospital for surgery to remove a small growth found on one of his lungs, the first major health issue of his 17-month tenure. Leo, 71, said on Sunday that t

· SRN Health
Pope Leo leaves Vatican for hospital ahead of surgery on lung nodule
health

J&J posts weak medical device sales, shares fall

By Michael Erman and Sriparna Roy Oct 13 (Reuters) – Johnson & Johnson reported sales in its medical devices business on Tuesday that fell short of Wall Street expectations, citing geopolitical issues including the Middle East conflict, and its shares fell more than 6%. The results marked the second

· SRN Health
J&J posts weak medical device sales, shares fall
health

UnitedHealth raises profit forecast as turnaround efforts gather pace

By Amina Niasse NEW YORK, Oct 13 (Reuters) – UnitedHealth Group raised its 2026 profit forecast on Tuesday and indicated that Wall Street’s current estimate for 2027 earnings was too low, saying it would build on restrained medical-cost spending in its health insurance business and improved margins

· SRN Health
UnitedHealth raises profit forecast as turnaround efforts gather pace
health

Cleanup In Multiple States After A Wild Weather Weekend

(Miami, FL) — Efforts to restore power and assess damages are ongoing today after Isaias [[ ee-sy-EE-us ]] made landfall Friday night as a Category 2 hurricane along the western Florida Panhandle. Five deaths are blamed on the storm, two in Florida, two in Alabama and another in South Carolina. Mean

· SRN Health
health

Bausch + Lomb CEO Saunders departs, Chairman Appio named interim chief

By Kunal Das Oct 12 (Reuters) – Bausch + Lomb said on Monday that CEO Brent Saunders will leave the eye-care company by mutual agreement with its board, sending its US-listed shares down more than 7%. The company did not disclose a reason for Saunders’ departure and did not immediately respond to a

· SRN Health
Bausch + Lomb CEO Saunders departs, Chairman Appio named interim chief
health

Steris doubles down on healthcare consumables with $2.1 billion Xodus buy

By Christy Santhosh Oct 12 (Reuters) – Medical equipment maker Steris will buy privately held Xodus Medical for $2.1 billion, adding surgical products designed to improve safety for patients and operating-room staff to its healthcare consumables business. The acquisition strengthens Steris’ push int

· SRN Health
health

Bristol Myers radiopharma cancer drug slows rare tumor progression in study

By Siddhi Mahatole Oct 12 (Reuters) – Bristol Myers Squibb said on Monday its experimental radiopharmaceutical cancer therapy significantly delayed disease progression in patients with rare, advanced gastrointestinal and pancreatic tumors that had progressed after earlier treatment. Shares of the dr

· SRN Health
health

Bristol Myers’ lung disease drug succeeds at lower dose in late-stage trial

By Padmanabhan Ananthan Oct 12 (Reuters) – Bristol Myers Squibb said on Monday a lower dose of its experimental drug slowed the progression of a serious lung-scarring disease, putting it on track to be a first-of-its-kind treatment if approved. The late-stage trial enrolled 1,255 patients with idiop

· SRN Health
Bristol Myers’ lung disease drug succeeds at lower dose in late-stage trial
health

WHO: Russia Confirms Death At Research Lab

(Geneva) — The World Health Organization said Saturday that Russia’s state health regulator confirmed the death of a lab worker at a plague research facility in Siberia. The WHO says no case of plague had been registered. A laboratory worker at a plague research institute in Siberia got sick and lat

· SRN Health
health

Over 500,000 People Still Without Power After Hurricane Isaias

(Miami, FL) — Crews are working to restore power to over a half-million customers after the first hurricane of the Atlantic season slammed the Southeastern U.S. At least four deaths are blamed on Hurricane Isaias [[ ee-sy-EE-us ]] which hit the Florida Panhandle Friday night causing heavy damage. Mi

· SRN Health
health

Kenya finds no new Ebola cases after 293 tests

Oct 11 (Reuters) – Kenya has not recorded any new cases of Ebola after conducting 293 tests since a positive patient died on October 5, the Ministry of Health said on Sunday. The country confirmed its first imported case of Ebola on October 6 after a citizen who travelled from the Democratic Republi

· SRN Health
Kenya finds no new Ebola cases after 293 tests